News & Updates

PharmEnable awarded PLG Collaboration Deal of the Year Award

PharmEnable awarded PLG Collaboration Deal of the Year Award

We are delighted that our business development team has been recognised with the prestigious Collaboration Deal of the Year Award by the Pharmaceutical Licensing Group for our shared-risk collaboration with Sosei Heptares, an international biopharmaceutical group. The...

read more
In focus: Unlocking the potential of GPCR targets

In focus: Unlocking the potential of GPCR targets

GPCR representation, the tertiary structure of bovine rhodopsin within the cell membrane (in grey). Source: Wikimedia Commons PharmEnable has recently partnered with Sosei Heptares to work on a challenging G protein-coupled receptor (GPCR) target for a neurology...

read more
PharmEnable wins Rising Star at UKBAA Angel Investment Award

PharmEnable wins Rising Star at UKBAA Angel Investment Award

We are delighted to announce that PharmEnable has been awarded Rising Star in the DeepTech Investment of the Year category at the UKBAA Angel Investment Awards 2021. The annual UKBAA Angel Investment awards, sponsored by Playfair Capital, recognise acknowledge the...

read more
PharmEnable welcome new Director of Drug Discovery

PharmEnable welcome new Director of Drug Discovery

PharmEnable are delighted to welcome Dr James Dale as Director of Drug Discovery. He will play a significant role in driving the direction of the business, taking responsibility for driving the small molecule drug discovery strategy at PharmEnable.

read more